The American biotech company said its two-antibody cocktail, REGEN-COV, caused a 100% reduction in symptomatic infection and roughly 50% lower overall rates of infection

The new purchase is part of a US government deal to secure nearly 1 million doses of Lilly's bamlanivimab

The agency said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19

The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data

Responding to a complaint by RTI activist Saket Gokhale, the commission said it has found no violation of the provisions of the model code in the issue

Regeneron Pharmaceuticals Inc. said Friday that independent monitors had recommended placing on hold enrollment of the most severely ill patients

President Donald Trump received a similar experimental antibody drug from Regeneron Pharmaceuticals Inc on an emergency basis when he was sickened with the coronavirus earlier this month

The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits

Trump, who tested positive for COVID-19 on October 1 and was admitted to a military hospital for three nights and four days, declared himself cured after he was treated with an experimental antibody drug cocktail

Dr Reddy's has teamed up with Russian Development Investment Fund (RDIF) to conduct trials and distribute 100 million doses of Sputnik V in India

Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals Inc that he received for his COVID-19, as tantamount to a cure in a video he posted last week

Scientists from the University of Toronto and the Lunenfeld-Tanenbaum Research Institute at Sinai Health used both blood samples and saliva from coronavirus patients to assess and compare antibody levels for over three months post the onset of the first symptom

The agreement, under the Trump administration's Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19

Donald Trump, who was admitted at Walter Reed National Military Medical centre on Friday, had received \"a single 8-gram dose\" of Regeneron's monoclonal antibody cocktail

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF)

The Phase III trial is expected to enroll up to 2,400 participants who live or work at facilities that have had a recently diagnosed case of COVID-19

While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks

Coronavirus vaccine: World leaders and organisations, except the United States, have already pledged $8 billion to research, manufacture and distribute a possible vaccine and treatments for COVID-19 apart from the individual efforts taken by the countries and its pharmaceutical firms

United States has been worst affected nation with 72,275 deaths, followed by the UK, Italy and Spain; as spread of coronavirus shows no sign of slowing down, researchers and various governments are doubling efforts to develop a vaccine

Biocon is developing a customised non-replicating measles virus based vaccine for coronavirus, a latest antigen therapy that can be commercialised quickly, along with two new generation repurposed drugs and an antibody diagnostic kit